Expression of fatty acyl-CoA binding proteins in colon cells: Response to butyrate and transformation

被引:23
作者
Gossett, RE
Schroeder, F
Gunn, JM
Kier, AB
机构
[1] TEXAS A&M UNIV,DEPT VET PATHOBIOL,TVMC,COLLEGE STN,TX 77843
[2] TEXAS A&M UNIV,DEPT VET PHYSIOL & PHARMACOL,TVMC,COLLEGE STN,TX 77843
[3] TEXAS A&M UNIV,DEPT BIOCHEM,TVMC,COLLEGE STN,TX 77843
关键词
D O I
10.1007/s11745-997-0073-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acyl-CoA affect many cellular functions as well as serving as cellular building blocks. Several families of cytosolic fatty acyl-CoA binding proteins may modulate the activities of fatty acyl-CoA. Intestinal enterocytes contain at least three unique families of cytosolic proteins that bind fatty acyl-CoA: acyl-CoA binding protein (ACBP), fatty acid binding proteins (including the liver, L-FABP and intestinal, l-FABP), and sterol carrier protein-2 (SCP-2). Immortalized rat colon epithelial cell lines expressed only ACBP and SCP-2 at levels of 0.75 +/- 0.13 and 0.42 +/- 0.02 ng/mu g protein. Ras and src transformation increased colon cell density and differentially altered ACBP and SCP-2 expression without affecting l-FABP or L-FABP levels. ACBP levels were 1.8-fold and 1.5-fold increased in ras- and src-transformed cells, respectively. In contrast, SCP-2 expression was significantly decreased 55 and 67% in ras- and src-transformed cells, respectively. Butyrate treatment of ras- and src-transformed cells decreased cell proliferation up to 60-85% as compared to 25-30% in control cells. Butyrate treatment decreased ACBP expression in all cell lines but had no effect on the levels of SCP-2, l-FABP, or L-FABP. These studies suggest that the differential expression of ACBP and SCP-2 in rat colonic cell lines, as well as their modulation by butyrate, may be altered by cell transformation.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 42 条
[1]  
ALHO H, 1995, CELL GROWTH DIFFER, V6, P309
[2]  
BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89
[3]   TISSUE EXPRESSION OF 3 STRUCTURALLY DIFFERENT FATTY-ACID BINDING-PROTEINS FROM RAT-HEART MUSCLE, LIVER, AND INTESTINE [J].
BASS, NM ;
MANNING, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 137 (03) :929-935
[4]   LIVER FATTY-ACID BINDING-PROTEIN - A MARKER FOR STUDYING CELLULAR-DIFFERENTIATION IN GUT EPITHELIAL NEOPLASMS [J].
CARROLL, SL ;
ROTH, KA ;
GORDON, JI .
GASTROENTEROLOGY, 1990, 99 (06) :1727-1735
[5]   ACTIVATION OF THE PP60C-SRC PROTEIN-KINASE IS AN EARLY EVENT IN COLONIC CARCINOGENESIS [J].
CARTWRIGHT, CA ;
MEISLER, AI ;
ECKHART, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :558-562
[6]   CHOLESTEROL INTERACTION WITH RECOMBINANT HUMAN STEROL CARRIER PROTEIN-2 [J].
COLLES, SM ;
WOODFORD, JK ;
MONCECCHI, D ;
MYERSPAYNE, SC ;
MCLEAN, LR ;
BILLHEIMER, JT ;
SCHROEDER, F .
LIPIDS, 1995, 30 (09) :795-803
[7]  
DAVIDSON NO, 1993, LAB INVEST, V68, P663
[8]   Sterol carrier protein-2, a new fatty acyl coenzyme A-binding protein [J].
Frolov, A ;
Cho, TH ;
Billheimer, JT ;
Schroeder, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :31878-31884
[9]   DIAZEPAM BINDING INHIBITOR IS A PARACRINE AUTOCRINE REGULATOR OF LEYDIG-CELL PROLIFERATION AND STEROIDOGENESIS - ACTION VIA PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR AND INDEPENDENT MECHANISMS [J].
GARNIER, M ;
BOUJRAD, N ;
OKE, BO ;
BROWN, AS ;
RIOND, J ;
FERRARA, P ;
SHOYAB, M ;
SUAREZQUIAN, CA ;
PAPADOPOULOS, V .
ENDOCRINOLOGY, 1993, 132 (01) :444-458
[10]  
GOLDSTEIN D, 1985, CANCER RES, V45, P3256